Hadas Sorotsky-Gantz
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-world treatment patterns and outcomes of chemo-immunotherapy with or without radiotherapy in extensive-stage small cell lung cancer: the durvalumab expanded access cohort.
Journal: Frontiers in oncology
Published: March 02, 2026
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study.
Journal: JTO clinical and research reports
Published: October 23, 2025
Real-World Data on Osimertinib-Associated Cardiac Toxicity.
Journal: Journal of clinical medicine
Published: January 27, 2025
Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery.
Journal: The British journal of radiology
Published: September 26, 2023
Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 16, 2022
RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era.
Journal: Cancers
Published: May 28, 2022
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 30, 2022
Chemoradiation followed by adjuvant durvalumab in stage III non-small cell lung cancer: Real-world comparison of treatment outcomes to historical controls treated with chemoradiation alone.
Journal: Thoracic cancer
Published: January 03, 2022
Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell Carcinoma.
Journal: Cancers
Published: December 26, 2021
New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer.
Journal: British journal of cancer
Published: September 05, 2015
Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief report.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 19, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026